News | February 22, 2012

U.S. Cardiology Practices Anticipate Using Fewer Imaging Exams to Diagnose Cardiac Conditions

February 22, 2012 — Cardiologists are expecting to use fewer imaging modalities per patient case in the future, according to a new report released by market research firm IMV Medical Information Division. The finding could indicate that efforts to crack down on the inappropriate use of medical imaging could be bearing fruit.

In 2008, cardiologists might have used three or four diagnostic imaging tests to diagnose a particular condition, but the recent research shows they are now inclined to use fewer types of exams. This trend may be the result of increasing use of appropriateness criteria guidelines for using medical imaging in cardiology, as well as growth in the use of increasingly restrictive precertification requirements for reimbursement of imaging tests, according to Lorna Young, senior director for Market Research at IMV.

For example, in October 2010, representatives from eight cardiology-related professional societies published new cardiac computed tomography (CT) appropriateness criteria to incorporate new data and clarify recommendations that may have previously been ambiguous.

"Consequently, while the use of CT angiography as a primary imaging modality is continuing to expand among U.S. cardiologists, its use has not caught on to the extent anticipated by cardiologists in IMV's prior 2006 and 2008 studies," Young said.

In addition, concerns about radiation exposure from advanced CT equipment may have limited its use as a primary imaging modality among cardiologists, Young observed. CT angiography is more frequently used as a follow-up test after positive results on echocardiography or single-photon emission computed tomography (SPECT) testing.

IMV's 2011 study, "Present Practices and Future Directions in Cardiac Imaging: The Cardiologist's Perspective, 2011-2014," was conducted with more than 200 U.S. cardiologists in July and August of 2011. The report is a sequel to IMV's prior 2006 and 2008 reports, and covers cardiologists' present and future use of advanced diagnostic imaging modalities for the full range of cardiac conditions that they see.

The new report explores trends since 2006 in the use and referral of cardiac CT angiography, CT calcium scoring, cardiac magnetic resonance (MR) and MR angiography, SPECT and SPECT/CT, positron emission tomography (PET) and PET/CT, cardiac catheterization, and echocardiography in cardiology practices. IMV's report details the use of these diagnostic imaging modalities for 11 key cardiac indications, including new and chronic angina, nonspecific chest pain, congestive heart failure, survivors of myocardial infarction, patients after coronary artery bypass surgery and patients after percutaneous coronary intervention.

Report highlights include:

  • Two-thirds of U.S. cardiologists order some CT angiography exams on a monthly basis, while more than 90 percent routinely order SPECT, echocardiography and cardiac catheterization procedures for their patients.
  • The aggressive shifting of cardiac procedures to CT angiography has not occurred at the rate predicted by cardiologists in the prior 2006 and 2008 studies. However, some shifting of CT angiography procedures continues to be anticipated by 2014.
  • More than 60 percent of the cardiology practices represented in the survey sample presently own or lease at least one piece of SPECT or SPECT/CT equipment, and 95 percent have at least one echocardiography unit in their practice.
  • Echocardiography represents one of the top two diagnostic imaging modalities for 10 of the 11 cardiac conditions covered in the survey.
  • While the use of MR and MR angiography was expected to become significantly more widespread by cardiologists in IMV's 2008 study, MR was not identified as a “top three modality” for any one of the 11 cardiac indications addressed in the 2011 survey. Going forward, MR angiography is expected to be a “top three modality” for evaluating valvular heart disease conditions by 2014.

For more information: www.imvinfo.com

Related Content

Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI) | September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Siemens Healthineers to Showcase Magentom Vida MRI at RSNA 2017
Technology | Magnetic Resonance Imaging (MRI) | September 18, 2017
September 18, 2017 — Siemens Healthineers announced it will display the new Magnetom Vida 3T...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT) | September 15, 2017
September 15, 2017 — Hitachi Healthcare Americas Inc. announced it has attained U.S.
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-I FPD to Save Patients' Limbs
News | Angiography | September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
Overlay Init